Satellos Bioscience, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   Follow-up Study of SAT-3247 · Duchenne Muscular Dystrophy…Follow-up Study of SAT-3247 · Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101

   Primary and study completion pushed from Aug 30, 2026 to Sep 30, 2027

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 10 → 30 participants

   Satellos Bioscience, Inc.·Phase 2· NCT06867107· Registry history of NCT06867107 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.